CardiacSense has Patented, Novel Bio-sensing Opto-Mechanical sensors which, in combination with advanced Artifact sensors, are capable of Beat by Beat and Breath by Breath Continuous Monitoring of all vital signs
MedTech solutions provider Xplore Lifestyle unveiled on Thursday CardiacSense – an easy-to-wear watch based on advanced cardiac and other vital signs monitoring technology. Xplore Lifestyle has brought the device in collaboration with an Israeli company.
Taking wearable technologies to a new level, CardiacSense is the first medical grade continuous vitals monitoring device launched globally. Eyal Copitt and Ido Mor from Cardiac Sense and Pankaj Balwani from Xplore Lifestyle addressed media after the unveiling.
Built with cutting-edge Israeli biosensing technologies, its patented optomechanical sensors, when combined with the proprietary PPG, ECG and Artifact sensing Technology and advanced algorithms, the watch can detect and read heart activity beat-by-beat. As a result, it can detect fatal Arrhythmia like AFib, and notify doctors and family members of patients instantly. It can also be used for patients suffering from chronic conditions such as BP (hypertension), Chronic Heart Failure (CHF) and other cardiac conditions.
The watch also has the capability to measure breath-by-breath respiratory rate and can track conditions such as COPD and Sleep Apnea. A watch being able to read respiratory rate is again world’s first.
“Patients with irregular heart rhythms (Arrhythmia) in most cases don’t realize that they may be suffering from some of the life-threatening abnormal heart rhythms. With Atrial Fibrillation being the most serious arrhythmias (irregular heartbeat) responsible for approximately 70% of ischemic strokes, CardiacSense is able to detect Atrial Fibrillation with over 99% accuracy. With CardiacSense, patients and their doctors will get alerts for life-threatening events. Also, doctors can look through saved recordings on the Mobile App and cloud for all vital signs of patients, and will be able to assess what had really happened with the patient during a cardiac event. This 24/7 continuous monitoring capability gives very useful information in the hands of doctors who can diagnose and quickly start the right treatment for such patients, said Pankaj Balwani, founder and CEO of Xplore Lifestyle.
The device – with a price tag of Rs 1 lakh- will be available in India from September 2022.
